Elpiscience is a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies for cancer patients worldwide. The company’s innovative approach is focused on targeting tumor microenvironment to identify effective mechanisms to kill cancer. A pipeline of novel molecules has been developed using its proprietary platforms. Through internal R&D expertise and partnerships with global biopharmaceutical companies, Elpiscience endeavors to advance the programs with breakthrough value into clinic use.
Our Vision
Innovate transformative medicines that improve cancer patients' lives worldwide.
Passion
Make everything possible!
Leadership
Let you win!
pleasure
Help you achieve your career!
Our Mission
To discover and develop novel high-quality cancer therapeutics efficiently.